{"id":"actrapid-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"},{"rate":null,"effect":"Weight gain"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Actrapid (human insulin injection) mimics endogenous insulin by binding to insulin receptors on muscle, fat, and liver cells, facilitating glucose transport into cells and promoting glycogen synthesis while inhibiting gluconeogenesis. This results in rapid reduction of postprandial and fasting blood glucose levels. It is a short-acting insulin formulation designed for mealtime glucose control in diabetes management.","oneSentence":"Actrapid is a rapid-acting human insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:59:17.538Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"}]},"trialDetails":[{"nctId":"NCT02556840","phase":"NA","title":"Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-04-25","conditions":"Maturity-Onset Diabetes of the Young","enrollment":46},{"nctId":"NCT07224321","phase":"PHASE2","title":"INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes","status":"RECRUITING","sponsor":"Mannkind Corporation","startDate":"2026-02","conditions":"Type 1 Diabetes Mellitus","enrollment":100},{"nctId":"NCT06671587","phase":"PHASE4","title":"iGlarLixi CGM Study in Chinese T2D Individuals After OADs","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-12-10","conditions":"Type 2 Diabetes (T2D)","enrollment":678},{"nctId":"NCT07463417","phase":"NA","title":"Evaluating the SWW Method Dietary Intervention for HbA1c and Weight Management as a Preventative Intervention in Women","status":"COMPLETED","sponsor":"Sarah Wragge Wellness","startDate":"2024-04-01","conditions":"Metabolic Syndrome, Obesity & Overweight, Blood Glucose Monitoring","enrollment":85},{"nctId":"NCT04149262","phase":"","title":"Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2019-11-15","conditions":"Type 1 Diabetes","enrollment":44},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT07439536","phase":"PHASE4","title":"Dose Optimization of Sitagliptin and Duloxetine in Diabetic Cirrhosis","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-07-01","conditions":"Liver Cirrhosis With Diabetes","enrollment":64},{"nctId":"NCT05018585","phase":"PHASE3","title":"A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diamyd Medical AB","startDate":"2022-05-19","conditions":"Type 1 Diabetes Mellitus","enrollment":330},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT07059091","phase":"PHASE2","title":"Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-02-12","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Allergies","enrollment":334},{"nctId":"NCT05508061","phase":"NA","title":"Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"Inreda Diabetic B.V.","startDate":"2022-10-19","conditions":"Type 1 Diabetes","enrollment":12},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT00903110","phase":"","title":"Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).","status":"RECRUITING","sponsor":"Esteve Pharmaceuticals, S.A.","startDate":"2008-12-09","conditions":"IGF1 Deficiency","enrollment":500},{"nctId":"NCT07387003","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Gan & Lee Pharmaceuticals.","startDate":"2026-03-20","conditions":"Type 2 Diabetes (T2DM)","enrollment":300},{"nctId":"NCT03956927","phase":"","title":"Feasibility of Simulation in Therapeutic Patient Education for Adult Diabetic Patients Using the Freestyle Libre® Device","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2019-05-24","conditions":"Insulin-Dependent Diabetes","enrollment":27},{"nctId":"NCT07276776","phase":"NA","title":"An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insulet Corporation","startDate":"2025-12-12","conditions":"Type 2 Diabetes Mellitus","enrollment":40},{"nctId":"NCT07373392","phase":"NA","title":"Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals With Prediabetes and Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Aalborg University","startDate":"2026-01-25","conditions":"Diabete Type 1, Diabete Type 2, Prediabetes","enrollment":210},{"nctId":"NCT07220694","phase":"NA","title":"Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance","status":"RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-01-29","conditions":"Insulin Resistance, Mild Cognitive Impairment, Cognitive Decline","enrollment":140},{"nctId":"NCT07364669","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Effects of Insulex® R in Comparison to Humulin® R in Healthy Subjects","status":"COMPLETED","sponsor":"Laboratorios Pisa S.A. de C.V.","startDate":"2024-10-24","conditions":"Healthy Subjects","enrollment":40},{"nctId":"NCT01239550","phase":"NA","title":"Insulin Detemir in Obesity Management","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University","startDate":"2011-04","conditions":"Diabetes, Obesity","enrollment":240},{"nctId":"NCT07061301","phase":"NA","title":"Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2024-08-01","conditions":"Type 2 Diabetes Mellitus (T2DM), Continuous Glucose Monitoring, CGM","enrollment":80},{"nctId":"NCT06547918","phase":"NA","title":"SmartAdjust 2.0 System With Type 1 and Type 2 Diabetes","status":"COMPLETED","sponsor":"Insulet Corporation","startDate":"2024-07-18","conditions":"Diabetes Mellitus","enrollment":48},{"nctId":"NCT07359625","phase":"NA","title":"Effects of Ketone Bodies on Insulin Sensitivity","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-12-02","conditions":"Insulin Resistance, Obesity & Overweight, Energy Metabolism","enrollment":10},{"nctId":"NCT06716424","phase":"PHASE4","title":"A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-01-06","conditions":"Type 2 Diabetes","enrollment":105},{"nctId":"NCT07353086","phase":"NA","title":"Evaluation of Horizontal Mandibular Ridge Augmentation Through Subperiosteal Tunneling by Using Bovine Sticky Bone (Radio-Histological Study)","status":"COMPLETED","sponsor":"Tanta University","startDate":"2024-08-25","conditions":"Posterior Mandible With Deficient Ridge Width","enrollment":10},{"nctId":"NCT06092476","phase":"NA","title":"Trial to Evaluate Efficacy+Safety of Revita DMR Treatment Paradigm 1 and Retreatment in Type 2 Diabetes Patients","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-08-09","conditions":"Diabetes Mellitus, Type 2","enrollment":18},{"nctId":"NCT07345143","phase":"NA","title":"Artificial Intelligence and Gestacional Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"JOSE FERNANDO VILELA-MARTIN","startDate":"2024-06-01","conditions":"Gestational Diabetes, Macrosomia, Fetal","enrollment":100},{"nctId":"NCT07325435","phase":"PHASE4","title":"Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists","status":"ACTIVE_NOT_RECRUITING","sponsor":"MaryAnn Banerji","startDate":"2024-12-21","conditions":"Type 2 Diabetes (T2DM)","enrollment":60},{"nctId":"NCT04952779","phase":"","title":"Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-06-02","conditions":"Diabetes Mellitus, Type 2","enrollment":750},{"nctId":"NCT05069545","phase":"","title":"A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-10-11","conditions":"Diabetes Mellitus, Type 1","enrollment":411},{"nctId":"NCT07311759","phase":"PHASE3","title":"Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-17","conditions":"Chronic Paronychia","enrollment":21},{"nctId":"NCT07308925","phase":"NA","title":"Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.","status":"NOT_YET_RECRUITING","sponsor":"Hospital Universitario San Ignacio","startDate":"2026-01-31","conditions":"Type 2 Diabetes","enrollment":108},{"nctId":"NCT05742243","phase":"PHASE2","title":"Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2023-02-13","conditions":"Type 1 Diabetes, Diabetes Mellitus, Type 1","enrollment":68},{"nctId":"NCT06082973","phase":"NA","title":"Dual-hormone Artificial Pancreas Versus Single-hormone Under Exercise and a Meal Challenge","status":"COMPLETED","sponsor":"Universitat Politècnica de València","startDate":"2024-05-15","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT04698018","phase":"PHASE1","title":"A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-04-20","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":23},{"nctId":"NCT07052292","phase":"","title":"User Experience With DuraTouch® in Patients With Type 1 or Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novo Nordisk A/S","startDate":"2025-07-01","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":125},{"nctId":"NCT04588259","phase":"PHASE3","title":"Research Study to Compare a New Medicine \"Fast-acting Insulin Aspart\" to Another Medicine \"Insulin Aspart\" in Chinese People With Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-10-09","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":331},{"nctId":"NCT05417841","phase":"NA","title":"Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM","status":"COMPLETED","sponsor":"Beijing Hospital","startDate":"2023-03-23","conditions":"Type 2 Diabetes Mellitus","enrollment":218},{"nctId":"NCT04225455","phase":"","title":"The Use of the Dexcom G6® in Commercial Pilots With Insulin-treated Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Surrey","startDate":"2019-12-05","conditions":"Insulin Dependent Diabetes","enrollment":17},{"nctId":"NCT05259449","phase":"NA","title":"Efficacy of Educational Nutrition and Exercise on the Regulation of Appetite Through Exosomes in Type 2 Diabetics","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cadiz","startDate":"2022-03-10","conditions":"Diabetes Mellitus, Type 2","enrollment":146},{"nctId":"NCT00597480","phase":"PHASE4","title":"Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-01","conditions":"Small for Gestational Age","enrollment":10},{"nctId":"NCT04419779","phase":"NA","title":"Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes","status":"SUSPENDED","sponsor":"Fractyl Health Inc.","startDate":"2021-03-08","conditions":"Type 2 Diabetes","enrollment":320},{"nctId":"NCT03857321","phase":"PHASE2","title":"Study of Nasal Insulin to Fight Forgetfulness - Device Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2019-04-12","conditions":"Mild Cognitive Impairment, Cognitive Impairment","enrollment":20},{"nctId":"NCT05081219","phase":"PHASE2","title":"SNIFF - Combo INI+EMPA Trial","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2021-09-14","conditions":"Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease","enrollment":47},{"nctId":"NCT07201155","phase":"","title":"The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2024-05-01","conditions":"Hyperglycemia in Critically Ill Patients","enrollment":55},{"nctId":"NCT06798402","phase":"PHASE2","title":"Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate","status":"RECRUITING","sponsor":"Al-Mustafa University College","startDate":"2025-02-07","conditions":"Cutaneous Leishmaniasis","enrollment":80},{"nctId":"NCT06797544","phase":"PHASE2","title":"Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis","status":"RECRUITING","sponsor":"Hayder Adnan Fawzi","startDate":"2025-02-09","conditions":"Cutaneous Leishmaniasis","enrollment":40},{"nctId":"NCT06291675","phase":"","title":"Gender-Affirming Hormone Therapy and Its Impact on Myocardial Mass and Cardiac Function, Heart, Liver and Pancreatic Fat Content","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-03-03","conditions":"Gender Dysphoria, Hormone Therapy Induced Morphologic Change","enrollment":50},{"nctId":"NCT03903016","phase":"PHASE1","title":"A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-03-26","conditions":"Type 1 Diabetes","enrollment":90},{"nctId":"NCT06880835","phase":"NA","title":"Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2025-06-05","conditions":"Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT07108426","phase":"NA","title":"Medical Education to Improve Diabetes Care and Outcomes in Hospitalized Patients","status":"COMPLETED","sponsor":"Catholic University of Pelotas","startDate":"2024-08-01","conditions":"Diabete Type 2, Hyperglycemic Therapy, Medical Education","enrollment":50},{"nctId":"NCT03298295","phase":"NA","title":"Inflammatory Response to CSII Catheters in a Tummy Tuck Model","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2018-02-01","conditions":"Diabetes Mellitus","enrollment":20},{"nctId":"NCT06794658","phase":"NA","title":"EFFICACY OF REMOTE MONITORING OF PATIENTS WITH DIABETES UNDER INSULIN TREATMENT, BY USING Caaring SOFTWARE","status":"RECRUITING","sponsor":"Persei Vivarium","startDate":"2024-12-11","conditions":"Diabetes Mellitus","enrollment":200},{"nctId":"NCT06349382","phase":"NA","title":"CArbohydrate Loading in Aortic Surgery","status":"COMPLETED","sponsor":"University of Belgrade","startDate":"2024-08-01","conditions":"Abdominal Aortic Aneurysm, Leriche Syndrome","enrollment":40},{"nctId":"NCT06820658","phase":"","title":"A Comparison of Neuromuscular Recruitment in Trained and Untrained Adults","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-02-26","conditions":"Healthy, Insulin Resistance","enrollment":80},{"nctId":"NCT05006599","phase":"PHASE2","title":"SNIFF - 3-Week Aptar CPS Device","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2025-05","conditions":"Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Disease, Early Onset","enrollment":""},{"nctId":"NCT04199767","phase":"PHASE2","title":"SNIFF Multi-Device Study 2","status":"SUSPENDED","sponsor":"Wake Forest University Health Sciences","startDate":"2020-07-16","conditions":"Mild Cognitive Impairment, Cognitive Impairment","enrollment":30},{"nctId":"NCT07070752","phase":"PHASE3","title":"Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus Patients","status":"COMPLETED","sponsor":"Geropharm","startDate":"2023-04-14","conditions":"Type 1 Diabetes Mellitis","enrollment":224},{"nctId":"NCT05570435","phase":"NA","title":"Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2022-11-16","conditions":"Healthy, PreDiabetes, Adult","enrollment":31},{"nctId":"NCT05224258","phase":"NA","title":"Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2022-03-17","conditions":"Type 1 Diabetes","enrollment":240},{"nctId":"NCT07027332","phase":"","title":"Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using Fibroscan","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2024-05-29","conditions":"Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease","enrollment":36},{"nctId":"NCT03229408","phase":"PHASE2","title":"Treating Inflammation in Polycystic Ovary Syndrome to Ameliorate Ovarian Dysfunction","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2018-12-05","conditions":"Polycystic Ovary Syndrome","enrollment":60},{"nctId":"NCT06999551","phase":"PHASE4","title":"Comparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.","status":"NOT_YET_RECRUITING","sponsor":"Les Laboratoires des Médicaments Stériles","startDate":"2025-07-01","conditions":"Diabetes Mellitus","enrollment":60},{"nctId":"NCT05780151","phase":"PHASE4","title":"Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)","status":"COMPLETED","sponsor":"Mira Zuidgeest","startDate":"2023-07-10","conditions":"Diabetes Mellitus, Type 2","enrollment":107},{"nctId":"NCT05284071","phase":"NA","title":"Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation","status":"COMPLETED","sponsor":"Northern Care Alliance NHS Foundation Trust","startDate":"2022-03-14","conditions":"Diabetes type1, Diabetes type2","enrollment":13},{"nctId":"NCT06295289","phase":"NA","title":"Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2023-10-16","conditions":"Diabetes Mellitus","enrollment":54},{"nctId":"NCT06144554","phase":"","title":"Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Insulet Corporation","startDate":"2023-09-25","conditions":"Type 1 Diabetes","enrollment":2200},{"nctId":"NCT06028503","phase":"NA","title":"ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community","status":"RECRUITING","sponsor":"Sam Houston State University","startDate":"2024-04-01","conditions":"Type 2 Diabetes","enrollment":60},{"nctId":"NCT01528189","phase":"NA","title":"Effect of High Dose Insulin on Infectious Complications Following Major Surgery","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2018-10-05","conditions":"Surgical Site Infection After Major Surgery","enrollment":460},{"nctId":"NCT04974528","phase":"PHASE3","title":"Afrezza® INHALE-1 Study in Pediatrics","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2021-09-29","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":319},{"nctId":"NCT04264897","phase":"PHASE3","title":"Antecedent Metabolic Health and Metformin Aging Study","status":"COMPLETED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2020-07-29","conditions":"Aging, Insulin Sensitivity, Chronic Disease","enrollment":101},{"nctId":"NCT04617795","phase":"NA","title":"Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Insulet Corporation","startDate":"2020-11-23","conditions":"Type 2 Diabetes Mellitus","enrollment":25},{"nctId":"NCT05419115","phase":"PHASE2","title":"Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure","status":"RECRUITING","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2022-11-17","conditions":"Heart Failure","enrollment":170},{"nctId":"NCT05243628","phase":"PHASE4","title":"Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2022-03-31","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT06894784","phase":"PHASE3","title":"A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2025-04","conditions":"Diabetes Type 1","enrollment":36},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT06834841","phase":"NA","title":"Dexmedetomidine and Fentanyl As Adjuvants to Hyperbaric Bupivacaine for the Prevention of Post-spinal Shivering in Hip Arthroplasty Surgeries","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2024-04-01","conditions":"Post Spinal Shivering","enrollment":100},{"nctId":"NCT06798415","phase":"PHASE2","title":"Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis","status":"RECRUITING","sponsor":"Hayder Adnan Fawzi","startDate":"2025-02-10","conditions":"Cutaneous Leishmaniasis","enrollment":40},{"nctId":"NCT05560971","phase":"NA","title":"Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2022-11-01","conditions":"PreDiabetes, Insulin Resistance, Overweight","enrollment":40},{"nctId":"NCT02542631","phase":"NA","title":"Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Calibra Medical, Inc.","startDate":"2015-08-01","conditions":"Diabetes Mellitus, Type 2","enrollment":278},{"nctId":"NCT04227769","phase":"PHASE2","title":"IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-01-13","conditions":"Diabetes Mellitus Type 2 in Obese, Inflammation, Metabolic Disease","enrollment":18},{"nctId":"NCT05205928","phase":"PHASE2, PHASE3","title":"Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2022-10-02","conditions":"Type 1 Diabetes, Diabetes Mellitus, Type 1","enrollment":28},{"nctId":"NCT05325294","phase":"NA","title":"Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2022-05-05","conditions":"Type 1 Diabetes","enrollment":244},{"nctId":"NCT06387199","phase":"PHASE2, PHASE3","title":"Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2024-12-01","conditions":"Type 1 Diabetes, Diabetes Mellitus","enrollment":26},{"nctId":"NCT05331339","phase":"","title":"Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy As Part of a National Telemedicine Program (ETAPES)","status":"COMPLETED","sponsor":"Centre Hospitalier Sud Francilien","startDate":"2022-11-02","conditions":"Type 2 Diabetes Mellitus","enrollment":68},{"nctId":"NCT01767909","phase":"PHASE2, PHASE3","title":"The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2014-01-08","conditions":"Amnestic Mild Cognitive Impairment, Alzheimer's Disease","enrollment":240},{"nctId":"NCT04702672","phase":"NA","title":"High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2023-01-01","conditions":"Type 2 Diabetes","enrollment":38},{"nctId":"NCT03789578","phase":"PHASE1","title":"A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2019-01-17","conditions":"Diabetes Mellitus, Type 2","enrollment":30},{"nctId":"NCT05923827","phase":"NA","title":"Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insulet Corporation","startDate":"2023-09-11","conditions":"Diabetes Mellitus, Type 1","enrollment":200},{"nctId":"NCT03987802","phase":"","title":"An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-01-20","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":42},{"nctId":"NCT04042441","phase":"","title":"A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2019-07-29","conditions":"Diabetes Mellitus, Type 2","enrollment":1122},{"nctId":"NCT03049306","phase":"PHASE2","title":"Propranolol for Sleep Apnea Therapy","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-02-15","conditions":"Obstructive Sleep Apnea","enrollment":24},{"nctId":"NCT05262387","phase":"PHASE1","title":"A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-02-14","conditions":"Diabetes Mellitus, Type 1","enrollment":25},{"nctId":"NCT06559722","phase":"PHASE3","title":"A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Tonghua Dongbao Pharmaceutical Co.,Ltd","startDate":"2024-08","conditions":"Type 2 Diabetes","enrollment":510},{"nctId":"NCT04223973","phase":"NA","title":"MEDTRUM A7+ TouchCare Insulin Patch Pump (MedInPS)","status":"COMPLETED","sponsor":"Medtrum France","startDate":"2020-01-29","conditions":"Diabetes Mellitus","enrollment":93},{"nctId":"NCT05036317","phase":"PHASE3","title":"Empagliflozin for the Treatment of Postprandial Hypoglycemia","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-03-11","conditions":"Postprandial Hypoglycemia","enrollment":40},{"nctId":"NCT05904743","phase":"PHASE4","title":"INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2023-07-07","conditions":"Diabetes Mellitus, Type 1","enrollment":141},{"nctId":"NCT06520293","phase":"NA","title":"Effects of a Single Oral Dose of Sweet Protein Sweelin® on Blood Glucose and Insulin Levels in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Amai Proteins","startDate":"2024-09","conditions":"Healthy Adults","enrollment":20},{"nctId":"NCT05403502","phase":"NA","title":"Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Tandem Diabetes Care, Inc.","startDate":"2022-08-31","conditions":"Type 1 Diabetes","enrollment":183},{"nctId":"NCT01424241","phase":"PHASE4","title":"Effects of Sandostatin LAR® in Acromegaly","status":"COMPLETED","sponsor":"Columbia University","startDate":"2006-10","conditions":"Acromegaly","enrollment":21}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":31,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["insulin"],"phase":"phase_3","status":"active","brandName":"Actrapid® (Insulin)","genericName":"Actrapid® (Insulin)","companyName":"SepNet - Critical Care Trials Group","companyId":"sepnet-critical-care-trials-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Actrapid is a rapid-acting human insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}